NewsSource: EClinCloud

Product Introduction | eCOA · Electronic Clinical Outcome Assessment System

3 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration


In December 2021, the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) issued the "Guiding Principles for the Application of Patient-Reported Outcomes in Drug Clinical Development (Trial)", which states: "Compared with paper PROs, ePROs have clear advantages in efficiency, real-time capability, flexibility, compliance, security, and patient privacy protection in data collection."


Subsequently, the "Technical Guidelines for the Implementation of Patient-Centered Clinical Trials (Draft for Comment)", issued in August 2022, stated: "Electronic COA (eCOA) offers advantages such as collecting real-time, authentic data and facilitating data transcription, and can be implemented together with wearable devices or mobile electronic platforms (such as mobile apps) to provide convenience for participants."


What Is EClinCloud eCOA?


EClinCloud eCOA is an electronic tool for clinical trials that simply, thoroughly, accurately, and in real time collects standard scale data from clinician-reported (ClinRO), patient-reported (PRO), non-clinician observer-reported (ObsRO), or performance-based (PerfO) assessments, as well as custom diary data such as adverse reactions (SAE) and dosing logs.


Compared with paper COA, eCOA provides higher data collection efficiency and better data quality.


01

Streamlined Management Workflows and Reduced Missing Data

Eliminates administrative errors and data loss that may occur when study sites manage paper COAs.

Article illustration


Article illustration


02

Flexible Notification Configuration to Improve Participant Compliance

Pre-configured notification settings enable multi-party, repeated reminders to ensure that participants complete their entries on time.

Article illustration



03

Built-in Customized Training to Support Efficient Participant Completion

Training programs can be customized for each study so that participants know how to complete entries and are willing to do so, improving completion efficiency.

Article illustration



04

Intelligent Assistance System to Improve Data Accuracy

Built-in edit checks and risk alerts eliminate ambiguous and conflicting data.

Article illustration



What Are the Features of the EClinCloud eCOA System?


Article illustration



What Services Does EClinCloud eCOA Provide?


Guided by senior eCOA experts, EClinCloud's specialized eCOA team provides sponsors with a one-stop solution.

● A specialized medical team designs optimal electronic completion workflows based on scientific considerations.


● A strong scale team provides end-to-end services including scale licensing acquisition, scale translation, and linguistic validation.


● A rigorous data management team provides professional data services including database build, standard reports, and custom report development.


● An efficient project management team provides end-to-end project management, customized device management, and related services.


● A 24/7 online customer support team provides timely user assistance.


● Access to a network of physician and specialist resources delivers more professional and reliable service for clients.



Why Choose EClinCloud eCOA?




Simple and Easy-to-Use System
01

The system is flexibly designed, user-friendly, clean, stable, and reliable, meeting various CDE requirements, and as an integrated platform enables more efficient data interfacing and integration.




Authentic and Accurate Data
02

Backed by a comprehensive quality control system to ensure the authenticity, accuracy, and integrity of eCOA data collection.




Professional and Experienced Team
03

With experienced medical and project teams, standardized end-to-end project management, and experience coordinating with multiple international copyright holders, EClinCloud provides one-stop service from scale selection to eCOA implementation.




Passed NMPA Inspection
04

Collecting patient data through the EClinCloud eCOA system yields more complete clinical endpoint data in a timely manner, ensures data authenticity, validity, and traceability, and can reshape the entire process for critical clinical trial data. It has been recognized by NMPA inspection experts and supports the marketing approval of drugs.






About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interconnected all-in-one clinical trial cloud platform (encompassing technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) along with clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, and ophthalmology). Combining cutting-edge technology with life data, it builds a globally leading "patient-centric" SaaS cloud platform for clinical evidence support to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article illustration

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.